Loading viewer...
conference
Format: PDF conference
Karyopharm Therapeutics presented at the HC Wainwright 26th Annual Global Investment Conference in September 2024, discussing selinexor (XPOVIO) development and commercialization. The presentation covers the company's refinancing transactions, 2024 financial guidance, and clinical development plans for selinexor across multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma.
conference
80 Pages
conference
72 Pages
Raymond James & Associates, Inc.
Keppel Infrastructure Trust 2024 HSBC MENAT Forum
conferenceconference
47 Pages
Keppel Infrastructure Trust